Eli Lyons – Disrupting Genome Science

Click PLAY to listen to Eli Lyons's interview

eli lyons tupac bio

About Eli Lyons

Disrupting Genome Science

In today’s conversation we are going to learn about bioinformatics -  an evolving biotech discipline that uses software to help us better understand biological data. Bionformatics is key to innovation in the current drug discovery process and disease prevention.  To that end we are joined by a PhD in Genome Science, based in Tokyo - Eli Lyons, CEO of Tupac Bio. Although Biotech is a highly skilled and technologically driven industry, it can often be slowed by traditional or internally focused worldviews. Eli applies his training as an engineer to a fundamentally biological problem to drive innovation. In this interview, Eli shares his own views on how being an outsider within any industry can yield new ways of thinking.

3 Startup Entrepreneurs Pioneering Asia’s $100 Billion Health Tech Industry

Asia’s health tech industry is worth over $100 billion. With a combination of aging populations, an emerging wealthy middle class and populations of billions, Asia is a land of opportunity. In this feature, we highlight 3 startup entrepreneurs pioneering the Asian health tech industry - from redefining pharmaceutical field sales to patient-doctor interaction to genome science.  Featuring: .
>> Go to the full episode page

Eli Lyons Show Notes

Get Regular Updates on The Asian Tech Ecosystem

asia tech podcast

Join our Weekly Asia Tech Podcast Newsletter

Every week we share the latest insights from the frontline of the Asian Tech Ecosystem in our podcast. Join 2048 entrepreneurs on the ATP weekly newsletter below by entering your email address.
Privacy guarantee: your email is 100% safe with us - we won't give it to anyone else.